
ALK’s allergy treatment ACARIZAX (12-SQ-HDM SLIT) now approved for children aged 5+ in Ireland
Studies suggest that allergic rhinitis is the most common allergic condition ALK has announced that ACARIZAX® has received a paediatric indication extension for the treatment of moderate to severe house dust mite allergic rhinitis disease, making it …